ZimVie (ZIMV) Stock Forecast, Price Target & Predictions
ZIMV Stock Forecast
ZimVie stock forecast is as follows: an average price target of $14.50 (represents a -14.20% downside from ZIMV’s last price of $16.90) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
ZIMV Price Target
The average price target for ZimVie (ZIMV) is $14.50 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $20.00 to $9.00. This represents a potential -14.20% downside from ZIMV's last price of $16.90.
ZIMV Analyst Ratings
According to 2 Wall Street analysts, ZimVie's rating consensus is 'Buy'. The analyst rating breakdown for ZIMV stock is 0 'Strong Buy' (0.00%), 1 'Buy' (50.00%), 0 'Hold' (0.00%), 1 'Sell' (50.00%), and 0 'Strong Sell' (0.00%).
ZimVie Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 16, 2024 | David Saxon | Needham | $20.00 | $16.68 | 19.90% | 18.34% |
| Dec 21, 2022 | - | Barclays | $9.00 | $8.70 | 3.45% | -46.75% |
The latest ZimVie stock forecast, released on May 16, 2024 by David Saxon from Needham, set a price target of $20.00, which represents a 19.90% increase from the stock price at the time of the forecast ($16.68), and a 18.34% increase from ZIMV last price ($16.90).
ZimVie Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 1 |
| Avg Price Target | - | - | $20.00 |
| Last Closing Price | $16.90 | $16.90 | $16.90 |
| Upside/Downside | -100.00% | -100.00% | 18.34% |
In the current month, the average price target of ZimVie stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to ZimVie's last price of $16.90. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jun 25, 2024 | Needham | Buy | Buy | Hold |
| May 16, 2024 | Needham | - | Buy | Upgrade |
| Aug 08, 2023 | Barclays | Underweight | Underweight | Hold |
| Dec 21, 2022 | Barclays | - | Underweight | Initialise |
ZimVie's last stock rating was published by Needham on Jun 25, 2024. The company gave ZIMV a "Buy" rating, the same as its previous rate.
ZimVie Financial Forecast
ZimVie Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | $202.87M | $224.90M | $225.43M | $229.12M | $214.58M | $234.56M | $235.60M | $261.60M |
| Avg Forecast | $116.91M | $102.75M | $118.45M | $118.70M | $115.75M | $101.40M | $115.00M | $116.00M | $213.00M | $196.00M | $212.00M | $207.00M | $237.00M | $215.00M | $233.37M | $224.87M | $260.70M |
| High Forecast | $116.91M | $102.75M | $118.45M | $118.70M | $115.75M | $101.40M | $115.00M | $116.00M | $213.00M | $196.00M | $212.00M | $207.00M | $237.00M | $215.00M | $233.37M | $224.87M | $260.70M |
| Low Forecast | $116.91M | $102.75M | $118.45M | $118.70M | $115.75M | $101.40M | $115.00M | $116.00M | $213.00M | $196.00M | $212.00M | $207.00M | $237.00M | $215.00M | $233.37M | $224.87M | $260.70M |
| # Analysts | - | - | - | - | - | 1 | - | 1 | 1 | - | - | - | - | - | - | - | - |
| Surprise % | - | - | - | - | - | - | - | - | - | 1.04% | 1.06% | 1.09% | 0.97% | 1.00% | 1.01% | 1.05% | 1.00% |
ZimVie's average Quarter revenue forecast for Dec 23 based on 1 analysts is $213.00M, with a low forecast of $213.00M, and a high forecast of $213.00M. ZIMV's average Quarter revenue forecast represents a 4.99% increase compared to the company's last Quarter revenue of $202.87M (Sep 23).
ZimVie EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | 1 | - | 1 | 1 | - | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - | - | - | $57.88M | $61.37M | $22.26M | $7.75M | $22.56M | $22.06M | $9.93M | $-18.30M |
| Avg Forecast | $12.99M | $11.42M | $13.16M | $13.19M | $12.86M | $11.27M | $12.78M | $12.89M | $23.67M | $21.78M | $23.56M | $23.00M | $26.34M | $23.89M | $25.93M | $24.99M | $28.97M |
| High Forecast | $12.99M | $11.42M | $13.16M | $13.19M | $12.86M | $11.27M | $12.78M | $12.89M | $23.67M | $21.78M | $23.56M | $23.00M | $26.34M | $23.89M | $25.93M | $24.99M | $28.97M |
| Low Forecast | $12.99M | $11.42M | $13.16M | $13.19M | $12.86M | $11.27M | $12.78M | $12.89M | $23.67M | $21.78M | $23.56M | $23.00M | $26.34M | $23.89M | $25.93M | $24.99M | $28.97M |
| Surprise % | - | - | - | - | - | - | - | - | - | 2.66% | 2.60% | 0.97% | 0.29% | 0.94% | 0.85% | 0.40% | -0.63% |
1 analysts predict ZIMV's average Quarter EBITDA for Dec 23 to be $23.67M, with a high of $23.67M and a low of $23.67M. This is -59.10% lower than ZimVie's previous annual EBITDA (Sep 23) of $57.88M.
ZimVie Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | 1 | - | 1 | 1 | - | - | - | - | - | - | - | - |
| Net Income | - | - | - | - | - | - | - | - | - | $-5.09M | $-23.37M | $-29.97M | $-30.34M | $831.00K | $-8.71M | $-25.66M | $-60.70M |
| Avg Forecast | $5.37M | $3.71M | $4.71M | $3.96M | $6.72M | $2.54M | $4.80M | $-1.10M | $3.43M | $-548.10K | $685.13K | $1.51M | $5.76M | $7.40M | $18.49M | $10.34M | $21.92M |
| High Forecast | $5.37M | $3.71M | $4.71M | $3.96M | $6.72M | $2.54M | $4.80M | $-1.10M | $3.43M | $-548.10K | $685.13K | $1.51M | $5.76M | $7.40M | $18.49M | $10.34M | $21.92M |
| Low Forecast | $5.37M | $3.71M | $4.71M | $3.96M | $6.72M | $2.54M | $4.80M | $-1.10M | $3.43M | $-548.10K | $685.13K | $1.51M | $5.76M | $7.40M | $18.49M | $10.34M | $21.92M |
| Surprise % | - | - | - | - | - | - | - | - | - | 9.28% | -34.11% | -19.88% | -5.27% | 0.11% | -0.47% | -2.48% | -2.77% |
ZimVie's average Quarter net income forecast for Dec 22 is $5.76M, with a range of $5.76M to $5.76M. ZIMV's average Quarter net income forecast represents a 592.55% increase compared to the company's last Quarter net income of $831.00K (Sep 22).
ZimVie SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | 1 | - | 1 | 1 | - | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - | - | - | $117.35M | $128.48M | $127.97M | $134.46M | $129.34M | $126.05M | $134.11M | $149.30M |
| Avg Forecast | $65.99M | $58.00M | $66.86M | $67.00M | $65.34M | $57.24M | $64.91M | $65.48M | $120.23M | $110.64M | $119.67M | $116.84M | $133.78M | $121.36M | $131.73M | $126.93M | $147.16M |
| High Forecast | $65.99M | $58.00M | $66.86M | $67.00M | $65.34M | $57.24M | $64.91M | $65.48M | $120.23M | $110.64M | $119.67M | $116.84M | $133.78M | $121.36M | $131.73M | $126.93M | $147.16M |
| Low Forecast | $65.99M | $58.00M | $66.86M | $67.00M | $65.34M | $57.24M | $64.91M | $65.48M | $120.23M | $110.64M | $119.67M | $116.84M | $133.78M | $121.36M | $131.73M | $126.93M | $147.16M |
| Surprise % | - | - | - | - | - | - | - | - | - | 1.06% | 1.07% | 1.10% | 1.01% | 1.07% | 0.96% | 1.06% | 1.01% |
ZimVie's average Quarter SG&A projection for Dec 23 is $120.23M, based on 1 Wall Street analysts, with a range of $120.23M to $120.23M. The forecast indicates a 2.45% rise compared to ZIMV last annual SG&A of $117.35M (Sep 23).
ZimVie EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | 1 | - | 1 | 1 | - | - | - | - | - | - | - | - |
| EPS | - | - | - | - | - | - | - | - | - | $-0.19 | $-0.89 | $-1.14 | $-1.16 | $0.03 | $-0.33 | $-0.98 | $-2.33 |
| Avg Forecast | $0.20 | $0.14 | $0.17 | $0.14 | $0.25 | $0.09 | $0.17 | $-0.04 | $0.13 | $-0.02 | $0.03 | $0.06 | $0.21 | $0.27 | $0.67 | $0.38 | $0.80 |
| High Forecast | $0.20 | $0.14 | $0.17 | $0.14 | $0.25 | $0.09 | $0.17 | $-0.04 | $0.13 | $-0.02 | $0.03 | $0.06 | $0.21 | $0.27 | $0.67 | $0.38 | $0.80 |
| Low Forecast | $0.20 | $0.14 | $0.17 | $0.14 | $0.25 | $0.09 | $0.17 | $-0.04 | $0.13 | $-0.02 | $0.03 | $0.06 | $0.21 | $0.27 | $0.67 | $0.38 | $0.80 |
| Surprise % | - | - | - | - | - | - | - | - | - | 9.50% | -35.60% | -20.73% | -5.52% | 0.11% | -0.49% | -2.60% | -2.91% |
According to 0 Wall Street analysts, ZimVie's projected average Quarter EPS for Dec 22 is $0.21, with a low estimate of $0.21 and a high estimate of $0.21. This represents a 600.00% increase compared to ZIMV previous annual EPS of $0.03 (Sep 22).
ZimVie Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| APYX | Apyx Medical | $1.08 | $8.50 | 687.04% | Buy |
| INGN | Inogen | $10.84 | $26.00 | 139.85% | Buy |
| OFIX | Orthofix Medical | $16.22 | $31.00 | 91.12% | - |
| CVRX | CVRx | $8.50 | $15.83 | 86.24% | Buy |
| NPCE | NeuroPace | $6.96 | $12.88 | 85.06% | Buy |
| SGHT | Sight Sciences | $6.83 | $10.33 | 51.24% | Hold |
| LUNG | Pulmonx | $8.18 | $12.25 | 49.76% | Buy |
| CNMD | CONMED | $74.80 | $101.00 | 35.03% | Buy |
| KIDS | OrthoPediatrics | $31.08 | $40.80 | 31.27% | Buy |
| SIBN | SI-BONE | $15.68 | $20.00 | 27.55% | Buy |
| AORT | Artivion | $25.22 | $30.00 | 18.95% | Buy |
| STE | STERIS | $241.68 | $245.00 | 1.37% | Buy |
| SRDX | Surmodics | $39.26 | $39.50 | 0.61% | Buy |
| ZIMV | ZimVie | $16.90 | $14.50 | -14.20% | Buy |
| SYK | Stryker | $363.95 | $305.00 | -16.20% | Buy |
ZIMV Forecast FAQ
Is ZimVie a good buy?
Yes, according to 2 Wall Street analysts, ZimVie (ZIMV) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 50.00% of ZIMV's total ratings.
What is ZIMV's price target?
ZimVie (ZIMV) average price target is $14.5 with a range of $9 to $20, implying a -14.20% from its last price of $16.9. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will ZimVie stock go up soon?
According to Wall Street analysts' prediction for ZIMV stock, the company can go down by -14.20% (from the last price of $16.9 to the average price target of $14.5), up by 18.34% based on the highest stock price target, and down by -46.75% based on the lowest stock price target.
Can ZimVie stock reach $30?
ZIMV's average twelve months analyst stock price target of $14.5 does not support the claim that ZimVie can reach $30 in the near future.
What are ZimVie's analysts' financial forecasts?
ZimVie's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $448.15M (high $448.15M, low $448.15M), average EBITDA is $49.8M (high $49.8M, low $49.8M), average net income is $12.96M (high $12.96M, low $12.96M), average SG&A $252.97M (high $252.97M, low $252.97M), and average EPS is $0.473 (high $0.473, low $0.473). ZIMV's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $456.81M (high $456.81M, low $456.81M), average EBITDA is $50.77M (high $50.77M, low $50.77M), average net income is $17.75M (high $17.75M, low $17.75M), average SG&A $257.86M (high $257.86M, low $257.86M), and average EPS is $0.648 (high $0.648, low $0.648).
Did the ZIMV's actual financial results beat the analysts' financial forecasts?
Based on ZimVie's last annual report (Dec 2022), the company's revenue was $913.86M, beating the average analysts forecast of $910.23M by 0.40%. Apple's EBITDA was $71.94M, missing the average prediction of $101.16M by -28.88%. The company's net income was $-63.881M, missing the average estimation of $41.98M by -252.16%. Apple's SG&A was $523.97M, beating the average forecast of $513.8M by 1.98%. Lastly, the company's EPS was $-2.45, missing the average prediction of $1.53 by -259.92%. In terms of the last quarterly report (Sep 2023), ZimVie's revenue was $202.87M, beating the average analysts' forecast of $196M by 3.51%. The company's EBITDA was $57.88M, beating the average prediction of $21.78M by 165.73%. ZimVie's net income was $-5.089M, beating the average estimation of $-548K by 828.48%. The company's SG&A was $117.35M, beating the average forecast of $110.64M by 6.07%. Lastly, the company's EPS was $-0.19, beating the average prediction of $-0.02 by 850.00%